Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) FCF Margin (2016 - 2025)

OptimizeRx's FCF Margin history spans 16 years, with the latest figure at 12.08% for Q3 2025.

  • For Q3 2025, FCF Margin rose 441.0% year-over-year to 12.08%; the TTM value through Sep 2025 reached 10.62%, up 1267.0%, while the annual FY2024 figure was 4.94%, 1518.0% up from the prior year.
  • FCF Margin for Q3 2025 was 12.08% at OptimizeRx, down from 15.59% in the prior quarter.
  • Across five years, FCF Margin topped out at 29.61% in Q1 2022 and bottomed at 22.08% in Q4 2023.
  • The 5-year median for FCF Margin is 7.66% (2024), against an average of 6.06%.
  • The largest annual shift saw FCF Margin skyrocketed 6416bps in 2021 before it tumbled -3626bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 6.76% in 2021, then surged by 310bps to 14.18% in 2022, then crashed by -256bps to 22.08% in 2023, then skyrocketed by 101bps to 0.29% in 2024, then soared by 4008bps to 12.08% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's FCF Margin are 12.08% (Q3 2025), 15.59% (Q2 2025), and 17.5% (Q1 2025).